article

1. Improving TRansitions ANd outcomeS for heart FailurE patients in home health CaRe (I-TRANSFER-HF): a type 1 hybrid effectiveness-implementation trial: study protocol..  BMC health services research.  24:-. 2024
2. Cardiac Myosin Inhibition in Heart Failure With Normal and Supranormal Ejection Fraction: Primary Results of the EMBARK-HFpEF Trial..  JAMA cardiology.  2024
3. Impact of Frailty and Delirium Among Older Adults Admitted With Acute Decompensated Heart Failure..  JACC. Advances.  3:-. 2024
4. The effect of down-titration and discontinuation of heart failure pharmacotherapy in older people: A systematic review and meta-analysis..  British journal of clinical pharmacology.  2024
5. Is It Time for Population-Based Screening for Transthyretin Cardiac Amyloidosis?.  JACC. Advances.  3:-. 2024
6. Trajectory of Cognitive Decline After Incident Heart Failure Hospitalization: Findings From the REGARDS Study..  Journal of the American Heart Association.  13:-. 2024
7. "It attracts your eyes and brain": Refining visualizations for shared decision-making with heart failure patients..  Applied clinical informatics.  2024
8. Physician-Reported Facilitators and Barriers for Side Effect Management of Heart Failure Medications..  Journal of the American Heart Association.  13:-. 2024
9. Race, Social Determinants of Health, and Comorbidity Patterns Among Participants with Heart Failure in the REasons for Geographic and Racial Differences in Stroke (REGARDS) Study..  Discover social science and health.  4. 2024
10. Polypharmacy and Guideline-Directed Medical Therapy Initiation Among Adults Hospitalized With Heart Failure..  JACC. Advances.  3:-. 2024
11. Discontinuation versus continuation of statins: A systematic review..  Journal of the American Geriatrics Society.  72:3567-3587. 2024
12. Comprehensive Geriatric Assessment to Optimize the Management of Older Patients With Transthyretin Cardiac Amyloidosis..  JACC. Advances.  3:-. 2024
13. Reductions in renin-angiotensin system inhibitors following hospitalization for heart failure..  ESC heart failure.  2024
14. Development and validation of mortality prediction models based on the social determinants of health..  Journal of epidemiology and community health.  78:508-514. 2024
15. Sarcopenia and aortic valve disease..  Heart (British Cardiac Society).  110:974-979. 2024
16. Palliative Pharmacotherapy for Cardiovascular Disease: A Scientific Statement From the American Heart Association..  Circulation. Cardiovascular quality and outcomes.  17:-. 2024
17. The Frailty Trajectory's Additional Edge Over the Frailty Index: Retrospective Cohort Study of Veterans With Heart Failure..  JMIR aging.  -. 2024
18. Is the Weight Over? An Improved HFpEF Risk Score..  JACC. Advances.  3:-. 2024
19. Cardiovascular Burden of the V142I Transthyretin Variant..  JAMA.  331:1824-1833. 2024
20. On-treatment analysis of torsemide versus furosemide for patients hospitalized for heart failure: A post-hoc analysis of TRANSFORM-HF..  European journal of heart failure.  26:1518-1523. 2024
21. Sex-Based Differences in the Epidemiology, Clinical Characteristics, and Outcomes Associated with Worsening Heart Failure Events in a Learning Health System..  Journal of cardiac failure.  30:981-990. 2024
22. Social Networks as a Key Health Determinant in Acute Illness Recovery: A Lesson from the COVID-19 Pandemic..  The American journal of medicine.  2024
23. Carpal Tunnel Syndrome and Transthyretin Amyloidosis in the All of Us Research Program..  Mayo Clinic proceedings.  99:1101-1111. 2024
24. Definition of Polypharmacy in Heart Failure: A Scoping Review of the Literature..  Cardiology research.  15:75-85. 2024
25. Aging in Heart Failure: Embracing Biology Over Chronology: JACC Family Series..  JACC. Heart failure.  12:795-809. 2024
26. Perceptions of Patient-Reported Outcome Data Access and Sharing among Patients with Heart Failure: Ethical Implications for Research..  European journal of cardiovascular nursing.  23:145-151. 2024
27. Impact of Advanced Therapy Centers on Characteristics and Outcomes of Heart Failure Admissions..  Circulation. Heart failure.  17:-. 2024
28. Cognitive Impairment Is Our Job Too..  Journal of cardiac failure.  30:423-424. 2024
29. Cognitive Impairment in Heart Failure: A Heart Failure Society of America Scientific Statement..  Journal of cardiac failure.  30:488-504. 2024
30. Initiation of Statins for Primary Prevention in Heart Failure With Preserved Ejection Fraction..  JACC. Advances.  3:-. 2024
31. Neighborhood Disadvantage and Risk of Heart Failure: The Reasons for Geographic and Racial Differences in Stroke (REGARDS) Study..  Circulation. Cardiovascular quality and outcomes.  17:-. 2024
32. Malnutrition and Sarcopenia as Reasons for Caution with GLP-1 Receptor Agonist Use in HFpEF..  Journal of cardiac failure.  30:610-612. 2024
33. Endovascular Ablation of the Right Greater Splanchnic Nerve in Heart Failure With Preserved Ejection Fraction: Rationale, Design and Lead-in Phase Results of the REBALANCE-HF Trial..  Journal of cardiac failure.  30:877-889. 2024
34. Association of Healthy Lifestyle and Incident Polypharmacy..  The American journal of medicine.  137:433-441.e2. 2024
35. Risk Prediction for Atherosclerotic Cardiovascular Disease With and Without Race Stratification..  JAMA cardiology.  9:55-62. 2024
36. Using Patient Decision Aids for Cardiology Care in Diverse Populations..  Current cardiology reports.  25:1543-1553. 2023
37. Health Status in Heart Failure and Cancer: Analysis of the Medicare Health Outcomes Survey 2016-2020..  JACC. Heart failure.  12:1166-1178. 2023
38. Social Determinants of Health and Cardiologist Involvement in the Care of Adults Hospitalized for Heart Failure..  JAMA network open.  6:-. 2023
39. Disparities in Guideline Concordant Statin Treatment in Individuals With Chronic Obstructive Pulmonary Disease..  Chronic obstructive pulmonary diseases (Miami, Fla.).  10:369-379. 2023
40. Myocardial infarction and physical function: the REasons for Geographic And Racial Differences in Stroke prospective cohort study..  BMJ public health.  1. 2023
41. How do we define high and low dose intensity of heart failure medications: a scoping review..  BMC cardiovascular disorders.  23:-. 2023
42. Malnutrition in heart failure with preserved ejection fraction..  Journal of the American Geriatrics Society.  71:3367-3375. 2023
43. Life's Essential 8: Optimizing Health in Older Adults..  JACC. Advances.  2. 2023
44. The Association of Intensive Blood Pressure Treatment and Non-Fatal Cardiovascular or Serious Adverse Events in Older Adults with Mortality: Mediation Analysis in SPRINT..  European journal of preventive cardiology.  30:996-1004. 2023
45. JACC: Advances.  JACC. Advances.  2. 2023
46. Geriatric Condition Burden in Cardiovascular Clinics..  JACC. Advances.  2:-. 2023
47. Prescribing patterns of fall risk-increasing drugs in older adults hospitalized for heart failure..  BMC cardiovascular disorders.  23:-. 2023
48. Acute Antipsychotic Use and Presence of Dysphagia Among Older Veterans with Heart Failure..  Journal of the American Medical Directors Association.  24:1303-1310. 2023
49. Allostatic load and incident heart failure in the Reasons for Geographic and Racial Differences in Stroke (REGARDS) study..  BMC cardiovascular disorders.  23:-. 2023
50. Opportunities and Achievement of Medication Initiation Among Inpatients With Heart Failure With Reduced Ejection Fraction..  JACC. Heart failure.  11:918-929. 2023
51. JACC: Advances.  JACC. Advances.  2. 2023
52. The median doses of beta-blockers among older adults with heart failure with reduced ejection fraction..  Journal of the American Geriatrics Society.  71:3322-3325. 2023
53. Passive Remote Monitoring for Prevention of Heart Failure Hospitalizations..  The American journal of medicine.  136:850-852. 2023
54. Dapagliflozin in Heart Failure With Mildly Reduced or Preserved Ejection Fraction According to Polypharmacy Status..  JACC. Heart failure.  11:1380-1393. 2023
55. Sarcopenia and Cardiovascular Diseases..  Circulation.  147:1534-1553. 2023
56. Brain fog in long COVID limits function and health status, independently of hospital severity and preexisting conditions..  Frontiers in neurology.  -. 2023
57. Stable Coronary Artery Disease in the Age of Geriatric Cardiology..  Journal of the American College of Cardiology.  81:1710-1713. 2023
58. Suboptimal Cardiology Follow-Up Among Patients With and Without Cancer Hospitalized for Heart Failure..  The American journal of cardiology.  79-86. 2023
59. Patient Awareness of Their Heart Failure Diagnosis and Its Implications for Epidemiologic Studies and Clinical Care..  The American journal of cardiology.  27-27.c3. 2023
60. Impact of acute TTE-evidenced cardiac dysfunction on in-hospital and outpatient mortality: A multicenter NYC COVID-19 registry study..  PloS one.  18:-. 2023
61. Social Determinants of Health and Cardiologist Involvement in the Care of Adults Hospitalized for Heart Failure..  medRxiv : the preprint server for health sciences.  2023
62. Home Health Care Workers' Interactions with Medical Providers, Home Care Agencies, and Family Members for Patients with Heart Failure..  Journal of the American Board of Family Medicine : JABFM.  36:369-375. 2023
63. Duration of Heightened Risk of Acute Ischemic Stroke After Hospitalization for Acute Systolic Heart Failure..  Journal of the American Heart Association.  12:-. 2023
64. Physician Perspectives on the Use of Beta Blockers in Heart Failure With Preserved Ejection Fraction..  The American journal of cardiology.  70-74. 2023
65. Mortality of patients with ST-segment-elevation myocardial infarction without standard modifiable risk factors among patients without known coronary artery disease: Age-stratified and sex-related analysis from nationwide readmissions database 2010-2014..  American journal of preventive cardiology.  -. 2023
66. Limited English Proficiency in Older Adults Referred to the Cardiovascular Team..  The American journal of medicine.  136:432-437. 2023
67. Real-world safety of neurohormonal antagonist initiation among older adults following a heart failure hospitalization..  ESC heart failure.  10:1623-1634. 2023
68. Implications of Under-Reporting Medication Side Effects: Beta-Blockers in Heart Failure as a Case Example..  Drugs & aging.  40:285-291. 2023
69. N-of-1 Trials for Pediatric Hypertension? A Promising Approach to Increasing the Precision of Antihypertensive Treatment..  American journal of hypertension.  36:87-89. 2023
70. Influence of social deprivation index on in-hospital outcomes of COVID-19..  Scientific reports.  13:-. 2023
71. Prediction of left ventricular ejection fraction changes in heart failure patients using machine learning and electronic health records: a multi-site study..  Scientific reports.  13:-. 2023
72. A RE-AIM Evaluation of a Visualization-Based Electronic Patient-Reported Outcome System..  Applied clinical informatics.  14:227-237. 2023
73. More COACHing Needed to Optimize Care after Heart Failure Hospitalization..  The New England journal of medicine.  388:82-83. 2023
74. Developing a Parsimonious Frailty Index for Older, Multimorbid Adults With Heart Failure Using Machine Learning..  The American journal of cardiology.  75-81. 2022
75. Does Connectedness Matter? The Association Between Mutuality and Job Satisfaction Among Home Health Aides Caring for Adults With Heart Failure..  Journal of applied gerontology : the official journal of the Southern Gerontological Society.  42:-. 2022
76. Returning study results to research participants: Data access, format, and sharing preferences..  International journal of medical informatics.  -. 2022
77. Population-Based Epidemiology of Heart Failure in a Low-Income Country: The Haiti Cardiovascular Disease Cohort..  Circulation. Cardiovascular quality and outcomes.  16:-. 2022
78. Molecular Mechanisms of Vascular Health: Insights From Vascular Aging and Calcification..  Arteriosclerosis, thrombosis, and vascular biology.  43:15-29. 2022
79. Development and Piloting of a Community-Partnered Heart Failure Training Course for Home Health Care Workers..  Circulation. Cardiovascular quality and outcomes.  15:-. 2022
80. The association between beta-blockers and outcomes in patients with heart failure and concurrent Alzheimer's disease and related dementias..  Journal of the American Geriatrics Society.  71:404-413. 2022
81. Medication Complexity Among Older Adults with HF: How Can We Assess Better?.  Drugs & aging.  39:851-861. 2022
82. Depressive symptoms, cognitive impairment, and all-cause mortality among REGARDS participants with heart failure..  European heart journal open.  2:-. 2022
83. Prevalence of Potentially Inappropriate Medication Prescribing in US Nursing Homes, 2013-2017..  Journal of general internal medicine.  38:1563-1566. 2022
84. Geriatric Domains in Patients with Heart Failure with Preserved Ejection Fraction..  Cardiology clinics.  40:517-532. 2022
85. Geriatric Cardiology: Coming of Age..  JACC. Advances.  1. 2022
86. Building trust in research through information and intent transparency with health information: representative cross-sectional survey of 502 US adults..  Journal of the American Medical Informatics Association : JAMIA.  29:1535-1545. 2022
87. Post-operative atrial fibrillation and risk of heart failure hospitalization..  European heart journal.  43:2971-2980. 2022
88. Outcomes of COVID-19 and Factors Associated With Its Severity Among Hospitalized Patients With and Without Systemic Rheumatic Disease During the First Wave of the Pandemic in New York City..  Journal of clinical rheumatology : practical reports on rheumatic & musculoskeletal diseases.  29:7-15. 2022
89. N-of-1 trials to facilitate evidence-based deprescribing: Rationale and case study..  British journal of clinical pharmacology.  88:4460-4473. 2022
90. Outcomes of patients with heart failure with preserved ejection fraction undergoing catheter ablation of atrial fibrillation..  Heart rhythm O2.  3:501-508. 2022
91. Post-ICU Syndrome in a Cohort of COVID-19 Survivors in New York City..  Annals of the American Thoracic Society.  19:1158-1168. 2022
92. The Prevalence of Adverse Drug Reactions and Adverse Drug Events from Heart Failure Medications in Frail Older Adults: A Systematic Review..  Drugs & aging.  39:631-643. 2022
93. Endovascular Ablation of the Right Greater Splanchnic Nerve in Heart Failure with Preserved Ejection Fraction: Early Results of the REBALANCE-HF Trial Roll-in Cohort..  European journal of heart failure.  24:1410-1414. 2022
94. Association of Perceived Stress With Incident Heart Failure..  Journal of cardiac failure.  28:1401-1410. 2022
95. Choices and Outcomes of the Oldest Old Admitted During the First Wave of COVID-19 in New York City..  Journal of palliative care.  37:-. 2022
96. Assessing mortality differences across acute respiratory failure management strategies in Covid-19..  Journal of critical care.  -. 2022
97. Heart failure and cognitive impairment: Complexity that requires a new approach..  Journal of the American Geriatrics Society.  70:1652-1654. 2022
98. Association of Transthyretin Val122Ile Variant With Incident Heart Failure Among Black Individuals..  JAMA.  327:1368-1378. 2022
99. What is the association of renin-angiotensin-aldosterone system inhibitors with COVID-19 outcomes: retrospective study of racially diverse patients?.  BMJ open.  12:-. 2022
100. Depressive Symptoms and Incident Hospitalization for Heart Failure: Findings From the REGARDS Study..  Journal of the American Heart Association.  11:-. 2022
101. Using Mobile Integrated Health and telehealth to support transitions of care among patients with heart failure (MIGHTy-Heart): protocol for a pragmatic randomised controlled trial..  BMJ open.  12:-. 2022
102. Healthcare Expenditure Associated With Polypharmacy in Older Adults With Cardiovascular Diseases..  The American journal of cardiology.  156-158. 2022
103. Health Status, Persistent Symptoms, and Effort Intolerance One Year After Acute COVID-19 Infection..  Journal of general internal medicine.  37:1218-1225. 2022
104. Causes and timing of 30-day rehospitalization from skilled nursing facilities after a hospital admission for pneumonia or sepsis..  PloS one.  17:-. 2022
105. Hospital market concentration and the use of mechanical circulatory support devices in acute myocardial infarction complicated by cardiogenic shock..  BMC health services research.  22:-. 2022
106. Atrial Fibrillation and Stroke Symptoms in the REGARDS Study..  Journal of the American Heart Association.  11:-. 2022
107. All-Cause Mortality as an End Point for Heart Failure With Preserved Ejection Fraction: Underperformance or Overambitious?.  Journal of cardiac failure.  28:863-865. 2022
108. New Antipsychotic Prescribing Continued into Skilled Nursing Facilities Following a Heart Failure Hospitalization: a Retrospective Cohort Study..  Journal of general internal medicine.  37:3368-3379. 2022
109. Beta-Blocker Use in Hypertension and Heart Failure (A Secondary Analysis of the Systolic Blood Pressure Intervention Trial)..  The American journal of cardiology.  58-64. 2021
110. Health care experiences during the COVID-19 pandemic by race and social determinants of health among adults age ≥ 58 years in the REGARDS study..  BMC public health.  21:-. 2021
111. Hyperglycemia in acute COVID-19 is characterized by insulin resistance and adipose tissue infectivity by SARS-CoV-2..  Cell metabolism.  33:-. 2021
112. Impact of Severe Acute Respiratory Syndrome Coronavirus 2 Viral Load on Risk of Intubation and Mortality Among Hospitalized Patients With Coronavirus Disease 2019..  Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.  73:e4197-e4205. 2021
113. Social Determinants of Health and 30-Day Readmissions Among Adults Hospitalized for Heart Failure in the REGARDS Study..  Circulation. Heart failure.  15:-. 2021
114. A proposal to accelerate widespread implementation of geriatric cardiology..  Trends in cardiovascular medicine.  33:21-22. 2021
115. Prescriptions for Potentially Inappropriate Medications from the Beers Criteria Among Older Adults Hospitalized for Heart Failure..  Journal of cardiac failure.  28:906-915. 2021
116. Changes in SARS-CoV-2 viral load and mortality during the initial wave of the pandemic in New York City..  PloS one.  16:-. 2021
117. Lack of Association Between Neurohormonal Blockade and Survival in Transthyretin Cardiac Amyloidosis..  Journal of the American Heart Association.  10:-. 2021
118. Association of healthy lifestyle and all-cause mortality according to medication burden..  Journal of the American Geriatrics Society.  70:415-428. 2021
119. Comparing automated vs. manual data collection for COVID-specific medications from electronic health records..  International journal of medical informatics.  -. 2021
120. Reply to: Comment on: The association between neurohormonal therapy and mortality in older adults with HFrEF..  Journal of the American Geriatrics Society.  70:306-307. 2021
121. Acute COVID-19-Associated Decrements in Left and Right Ventricular Function Predict All-Cause Mortality..  Journal of the American Society of Echocardiography : official publication of the American Society of Echocardiography.  35:229-234. 2021
122. Hyperglycemia in acute COVID-19 is characterized by insulin resistance and adipose tissue infectivity by SARS-CoV-2..  Cell metabolism.  33:2174-2188.e5. 2021
123. Clinical Characteristics and Outcomes of Adults With a History of Heart Failure Hospitalized for COVID-19..  Circulation. Heart failure.  14:-. 2021
124. Association Between Cervical Artery Dissection and Aortic Dissection..  Circulation.  144:840-842. 2021
125. Thirty-Day Readmission Rates after Takotsubo Syndrome with or without Malignancy: A Nationwide Readmissions Database Analysis..  Journal of clinical medicine.  10. 2021
126. Identifying organ dysfunction trajectory-based subphenotypes in critically ill patients with COVID-19..  Scientific reports.  11:-. 2021
127. Association of body mass index with morbidity in patients hospitalised with COVID-19..  BMJ open respiratory research.  8. 2021
128. Time to benefit and harm of intensive blood pressure treatment: insights from SPRINT..  European heart journal. Quality of care & clinical outcomes.  7:e1-e2. 2021
129. Sex-Related Differences in Clinical Presentation and Risk Factors for Mortality in Patients Hospitalized With Coronavirus Disease 2019 in New York City..  Open forum infectious diseases.  8:-. 2021
130. Development of the Verbal Autopsy Instrument for COVID-19 (VAIC)..  Journal of general internal medicine.  36:3522-3529. 2021
131. Impact of hospital transfer to hubs on outcomes of cardiogenic shock in the real world..  European journal of heart failure.  23:1927-1937. 2021
132. The association between neurohormonal therapy and mortality in older adults with heart failure with reduced ejection fraction..  Journal of the American Geriatrics Society.  69:2811-2820. 2021
133. Thirty-Day Post-Discharge Outcomes Following COVID-19 Infection..  Journal of general internal medicine.  36:2378-2385. 2021
134. Prefrailty, impairment in physical function, and risk of incident heart failure among older adults..  Journal of the American Geriatrics Society.  69:2486-2497. 2021
135. Polypharmacy in Heart Failure: Progress But Also Problem..  The American journal of medicine.  134:1071-1073. 2021
136. Remdesivir Versus Standard-of-Care for Severe Coronavirus Disease 2019 Infection: An Analysis of 28-Day Mortality..  Open forum infectious diseases.  8:-. 2021
137. Prescribing Trend of Inappropriate Medications in Outpatient Clinics for Older Adults With Heart Failure in the United States: NAMCS 2012 to 2016..  The American journal of cardiology.  -. 2021
138. Reply to Rhoads, et al..  Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.  72:-. 2021
139. Reply to "Simple Methods for Predicting Cardiovascular Readmission After a Heart Failure Hospitalization"..  The American journal of cardiology.  130-131. 2021
140. Attitudes toward deprescribing among adults with heart failure with preserved ejection fraction..  Journal of the American Geriatrics Society.  69:1948-1955. 2021
141. The Dietary Approaches to Stop Hypertension (DASH) Diet Pattern and Incident Heart Failure..  Journal of cardiac failure.  27:512-521. 2021
142. Hyperglycemia in Acute COVID-19 is Characterized by Adipose Tissue Dysfunction and Insulin Resistance..  medRxiv : the preprint server for health sciences.  2021
143. Response by Unlu et al to Letter Regarding Article, "Polypharmacy in Older Adults Hospitalized for Heart Failure"..  Circulation. Heart failure.  14:-. 2021
144. Frailty and Post-hospitalization Outcomes in Patients With Heart Failure With Preserved Ejection Fraction..  The American journal of cardiology.  84-93. 2021
145. Failure of chronic hydroxychloroquine in preventing severe complications of COVID-19 in patients with rheumatic diseases..  Rheumatology advances in practice.  5:-. 2021
146. Role for digoxin in patients hospitalized with COVID-19 and atrial arrhythmias..  Journal of cardiovascular electrophysiology.  32:880-881. 2021
147. COVID-19 in Patients with CKD in New York City..  Kidney360.  2:63-70. 2021
148. Human Immunodeficiency Virus-Associated Myocardial Diastolic Dysfunction and Soluble ST2 Concentration in Tanzanian Adults: A Cross-Sectional Study..  The Journal of infectious diseases.  223:83-93. 2021
149. Response by Pinheiro et al to Letter Regarding Article, "Multiple Vulnerabilities to Health Disparities and Incident Heart Failure Hospitalization in the REGARDS Study"..  Circulation. Cardiovascular quality and outcomes.  13:-. 2020
150. Gerotechnology for Older Adults With Cardiovascular Diseases: JACC State-of-the-Art Review..  Journal of the American College of Cardiology.  76:2650-2670. 2020
151. Outcomes of Hospitalizations for Cardiogenic Shock at Left Ventricular Assist Device Versus Non-Left Ventricular Assist Device Centers..  Journal of the American Heart Association.  9:-. 2020
152. Prognostic Utility of Right Ventricular Remodeling Over Conventional Risk Stratification in Patients With COVID-19..  Journal of the American College of Cardiology.  76:1965-1977. 2020
153. Utilizing electronic health data and machine learning for the prediction of 30-day unplanned readmission or all-cause mortality in heart failure..  Cardiovascular digital health journal.  1:71-79. 2020
154. Inclusion of Performance Parameters and Patient Context in the Clinical Practice Guidelines for Heart Failure..  Journal of cardiac failure.  27:190-197. 2020
155. Outcomes and mortality associated with atrial arrhythmias among patients hospitalized with COVID-19..  Journal of cardiovascular electrophysiology.  31:3077-3085. 2020
156. Polypharmacy in Older Adults Hospitalized for Heart Failure..  Circulation. Heart failure.  13:-. 2020
157. Characteristics of Acute Kidney Injury in Hospitalized COVID-19 Patients in an Urban Academic Medical Center..  Clinical journal of the American Society of Nephrology : CJASN.  16:284-286. 2020
158. D-dimer cut-off points and risk of venous thromboembolism in adult hospitalized patients with COVID-19..  Thrombosis research.  318-321. 2020
159. Arrhythmic Complications of Patients Hospitalized With COVID-19: Incidence, Risk Factors, and Outcomes..  Circulation. Arrhythmia and electrophysiology.  13:-. 2020
160. SARS-CoV-2 Viral Load Predicts Mortality in Patients with and without Cancer Who Are Hospitalized with COVID-19..  Cancer cell.  38:661-671.e2. 2020
161. Respiratory Mechanics and Gas Exchange in COVID-19-associated Respiratory Failure..  Annals of the American Thoracic Society.  17:1158-1161. 2020
162. Complex and Potentially Harmful Medication Patterns in Heart Failure with Preserved Ejection Fraction..  The American journal of medicine.  134:374-382. 2020
163. Performance of Electronic Health Record Diagnosis Codes for Ambulatory Heart Failure Encounters..  Journal of cardiac failure.  26:1060-1066. 2020
164. Multiple Vulnerabilities to Health Disparities and Incident Heart Failure Hospitalization in the REGARDS Study..  Circulation. Cardiovascular quality and outcomes.  13:-. 2020
165. Safety, tolerability, and clinical outcomes of hydroxychloroquine for hospitalized patients with coronavirus 2019 disease..  PloS one.  15:-. 2020
166. Obesity and COVID-19 in New York City: A Retrospective Cohort Study..  Annals of internal medicine.  173:855-858. 2020
167. Risk of Ischemic Stroke in Patients With Coronavirus Disease 2019 (COVID-19) vs Patients With Influenza..  JAMA neurology.  77:1-7. 2020
168. Electrocardiographic Findings in Coronavirus Disease-19: Insights on Mortality and Underlying Myocardial Processes..  Journal of cardiac failure.  26:626-632. 2020
169. Characterization and clinical course of 1000 patients with coronavirus disease 2019 in New York: retrospective case series..  BMJ (Clinical research ed.).  -. 2020
170. Risk of Ischemic Stroke in Patients with Covid-19 versus Patients with Influenza..  medRxiv : the preprint server for health sciences.  2020
171. Implementing a Proactive Deprescribing Approach to Prevent Adverse Drug Events..  Journal of general internal medicine.  35:3694-3696. 2020
172. Characterization and clinical course of 1000 Patients with COVID-19 in New York: retrospective case series..  medRxiv : the preprint server for health sciences.  2020
173. Hearing Loss and Physical Functioning Among Adults with Heart Failure: Data from NHANES..  Clinical interventions in aging.  635-643. 2020
174. Visual analogies, not graphs, increase patients' comprehension of changes in their health status..  Journal of the American Medical Informatics Association : JAMIA.  27:677-689. 2020
175. Social Determinants of Health and 90-Day Mortality After Hospitalization for Heart Failure in the REGARDS Study..  Journal of the American Heart Association.  9:-. 2020
176. Virtual Visits for Care of Patients with Heart Failure in the Era of COVID-19: A Statement from the Heart Failure Society of America..  Journal of cardiac failure.  26:448-456. 2020
177. Clinical Characteristics of Covid-19 in New York City..  The New England journal of medicine.  382:2372-2374. 2020
178. The association of hypertension, hypertension duration, and control with incident heart failure in black and white adults..  Journal of clinical hypertension (Greenwich, Conn.).  22:857-866. 2020
179. Specialty-Based Variability in Diagnosing and Managing Heart Failure With Preserved Ejection Fraction..  Mayo Clinic proceedings.  95:669-675. 2020
180. Older Adults Can Successfully Monitor Symptoms Using an Inclusively Designed Mobile Application..  Journal of the American Geriatrics Society.  68:1313-1318. 2020
181. Association of Hospital Volume with 30-Day Readmission Following Left Ventricular Assist Device Implantation..  Journal of cardiac failure.  26:349-351. 2020
182. Relation of a Simple Cardiac Co-Morbidity Count and Cardiovascular Readmission After a Heart Failure Hospitalization..  The American journal of cardiology.  125:1529-1535. 2020
183. Assembling and validating a heart failure-free cohort from the Reasons for Geographic and Racial Differences in Stroke (REGARDS) study..  BMC medical research methodology.  20:-. 2020
184. Age and Heart Failure Trials - Lessons from DAPA-HF..  Journal of cardiac failure.  26:191-192. 2020
185. Reply: Toward Improved Understanding of Potential Harm in Heart Failure..  JACC. Heart failure.  8:247-248. 2020
186. Efficacy and Safety of Intensive Blood Pressure Therapy Using Restricted Mean Survival Time-Insights from the SPRINT Trial..  The American journal of medicine.  133:e369-e370. 2020
187. Comment on: Lipid screening and statins alongside disease-modifying anti-rheumatic drugs for patients with rheumatoid arthritis: reply..  Rheumatology (Oxford, England).  59:454-455. 2020
188. Patient-Reported Barriers and Facilitators to Deprescribing Cardiovascular Medications..  Drugs & aging.  37:125-135. 2020
189. Prescribing Patterns of Heart Failure-Exacerbating Medications Following a Heart Failure Hospitalization..  JACC. Heart failure.  8:25-34. 2019
190. Perspectives on Implementing a Multidomain Approach to Caring for Older Adults With Heart Failure..  Journal of the American Geriatrics Society.  67:2593-2599. 2019
191. Physician Perspectives on Deprescribing Cardiovascular Medications for Older Adults..  Journal of the American Geriatrics Society.  68:78-86. 2019
192. Do We Need Shared Decision Making When Prescribing Guideline-Directed Medical Therapy?.  Journal of cardiac failure.  25:701-702. 2019
193. Cardiac Rehabilitation to Optimize Medication Regimens in Heart Failure..  Clinics in geriatric medicine.  35:549-560. 2019
194. Lipid screening and statins alongside disease-modifying anti-rheumatic drugs for patients with rheumatoid arthritis..  Rheumatology (Oxford, England).  58:933-934. 2019
195. Deprescribing in Older Adults With Cardiovascular Disease..  Journal of the American College of Cardiology.  73:2584-2595. 2019
196. Indications for β-Blocker Prescriptions in Heart Failure with Preserved Ejection Fraction..  Journal of the American Geriatrics Society.  67:1461-1466. 2019
197. Association of Urine Albumin Excretion With Incident Heart Failure Hospitalization in Community-Dwelling Adults..  JACC. Heart failure.  7:394-401. 2019
198. Prevalence and determinants of Hyperpolypharmacy in adults with heart failure: an observational study from the National Health and Nutrition Examination Survey (NHANES)..  BMC cardiovascular disorders.  19:-. 2019
199. Use of the Palliative Performance Scale to estimate survival among home hospice patients with heart failure..  ESC heart failure.  6:371-378. 2019
200. Association Between Heart Transplantation and Subsequent Risk of Stroke Among Patients With Heart Failure..  Stroke.  50:583-587. 2019
201. Medication-Taking Behaviors and Perceptions Among Adults With Heart Failure (from the REasons for Geographic And Racial Differences in Stroke Study)..  The American journal of cardiology.  123:1667-1674. 2019
202. Facilitated Peer Mentorship to Support Aging Research: A RE-AIM Evaluation of the CoMPAdRE Program..  Journal of the American Geriatrics Society.  67:804-810. 2019
203. Short-Term Risk of Ischemic Stroke After Detection of Left Ventricular Thrombus on Cardiac Magnetic Resonance Imaging..  Journal of stroke and cerebrovascular diseases : the official journal of National Stroke Association.  28:1027-1031. 2019
204. The Prevalence of Cognitive Impairment Among Adults With Incident Heart Failure: The "Reasons for Geographic and Racial Differences in Stroke" (REGARDS) Study..  Journal of cardiac failure.  25:130-136. 2018
205. Time to Get Going on Involving FITs in Clinical Trials..  Journal of the American College of Cardiology.  72:2802-2805. 2018
206. Association Between Functional Impairment and Medication Burden in Adults with Heart Failure..  Journal of the American Geriatrics Society.  67:284-291. 2018
207. Use of Heart Failure-Exacerbating Medications Among Adults With Heart Failure..  Journal of cardiac failure.  25:72-73. 2018
208. Atrial fibrillation and heart failure with preserved ejection fraction: Insights on a unique clinical phenotype from a nationally-representative United States cohort..  International journal of cardiology.  112-118. 2018
209. New uses of old technology: Can nurse-pagers improve communication between resident-physicians and nurses..  Applied nursing research : ANR.  1-5. 2018
210. Domain Management Approach to Heart Failure in the Geriatric Patient: Present and Future..  Journal of the American College of Cardiology.  71:1921-1936. 2018
211. Causes and Temporal Patterns of 30-Day Readmission Among Older Adults Hospitalized With Heart Failure With Preserved or Reduced Ejection Fraction..  Journal of the American Heart Association.  7. 2018
212. Discharge Processes and 30-Day Readmission Rates of Patients Hospitalized for Heart Failure on General Medicine and Cardiology Services..  The American journal of cardiology.  121:1076-1080. 2018
213. Temporal Trends in the Clinical Acuity of Patients with ST-Segment Elevation Myocardial Infarction..  The American journal of medicine.  131:100.e9-100.e20. 2017
214. Characteristics of hospitalizations for cardiogenic shock after acute myocardial infarction in the United States..  International journal of cardiology.  213-219. 2017
215. Invasive Hemodynamic Assessment of Patients with Heart Failure and Pulmonary Hypertension..  Current treatment options in cardiovascular medicine.  19:-. 2017
216. Sex- and Race-Related Differences in Characteristics and Outcomes of Hospitalizations for Heart Failure With Preserved Ejection Fraction..  Journal of the American Heart Association.  6. 2017
217. Patterns of scheduled follow-up appointments following hospitalization for heart failure: insights from an urban medical center in the United States..  Clinical interventions in aging.  1325-1332. 2016
218. Impact of Exercise Programs on Hospital Readmission Following Hospitalization for Heart Failure: A Systematic Review..  Current cardiovascular risk reports.  10. 2016
219. Electrophysiology and heart rhythm disorders in older adults..  Journal of geriatric cardiology : JGC.  13:645-651. 2016
220. Syncope in older adults..  Journal of geriatric cardiology : JGC.  13:380-6. 2016
221. Characteristics of Hospitalizations for Heart Failure with Preserved Ejection Fraction..  The American journal of medicine.  129:635.e15-26. 2016
222. Comparison of Trends in Incidence, Revascularization, and In-Hospital Mortality in ST-Elevation Myocardial Infarction in Patients With Versus Without Severe Mental Illness..  The American journal of cardiology.  117:1405-10. 2016
223. Association of Right Ventricular Pressure and Volume Overload with Non-Ischemic Septal Fibrosis on Cardiac Magnetic Resonance..  PloS one.  11:-. 2016
224. Myocardial perfusion pattern for stratification of ischemic mitral regurgitation response to percutaneous coronary intervention..  Coronary artery disease.  26:642-50. 2015
225. Cardiometabolic impact of non-statin lipid lowering therapies..  Current atherosclerosis reports.  16:-. 2014
226. Geometry-independent inclusion of basal myocardium yields improved cardiac magnetic resonance agreement with echocardiography and necropsy quantified left-ventricular mass..  Journal of hypertension.  31:2069-76. 2013
227. Mitral apparatus assessment by delayed enhancement CMR: relative impact of infarct distribution on mitral regurgitation..  JACC. Cardiovascular imaging.  6:220-34. 2013
228. Cardiovascular magnetic resonance imaging for assessment of cardiac thrombus..  Methodist DeBakey cardiovascular journal.  9:132-6. 2013
229. Variability among research diagnostic interview instruments in the application of DSM-IV-TR criteria for pediatric bipolar disorder..  Journal of the American Academy of Child and Adolescent Psychiatry.  51:605-21. 2012
230. Incidence, prognosis, and factors associated with cardiac arrest in patients hospitalized with acute coronary syndromes (the Global Registry of Acute Coronary Events Registry)..  Coronary artery disease.  23:105-12. 2012
231. Improved left ventricular mass quantification with partial voxel interpolation: in vivo and necropsy validation of a novel cardiac MRI segmentation algorithm..  Circulation. Cardiovascular imaging.  5:137-46. 2011
232. Risperidone use in children with Down syndrome, severe intellectual disability, and comorbid autistic spectrum disorders: a naturalistic study..  Journal of developmental and behavioral pediatrics : JDBP.  29:106-16. 2008
233. Neurobehavioral disorders in children, adolescents, and young adults with Down syndrome..  American journal of medical genetics. Part C, Seminars in medical genetics.  142C:158-72. 2006